Aastrom Biosciences Stock Rating Lowered by Roth Capital (ASTM)
Jags Report
Aastrom Biosciences Inc logo Roth Capital downgraded shares of Aastrom Biosciences (NASDAQ: ASTM) from a buy rating to a neutral rating in a report issued on Monday. They currently have $2.30 target price on the stock, down from their previous target ...
Biotech Stocks Under $5 (STEM, GERN, ASTM)Expedated

all 2 news articles »


More...